S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Maria-Victoria Mateos, Daniel Morillo, Moshe Gatt, Michael Sebag, Kihyun Kim, Chang-Ki Min, Albert Oriol, Enrique Ocio, Sung-Soo Yoon, Yael Cohen, Michael Chu, Paula Rodríguez-Otero, Irit Avivi, Yue Guo, Maria Krevvata, Michelle Peterson, Melissa Beelen, Jill Vanak, Arnob Banerjee, Hila Magen

Open source

DOI: 10.1097/01.hs9.0000967672.15362.d7
Published: 2023-08
Container: HemaSphere
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/01.hs9.0000967672.15362.d7,
  title = {S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)},
  author = {Maria-Victoria Mateos and Daniel Morillo and Moshe Gatt and Michael Sebag and Kihyun Kim and Chang-Ki Min and Albert Oriol and Enrique Ocio and Sung-Soo Yoon and Yael Cohen and Michael Chu and Paula Rodríguez-Otero and Irit Avivi and Yue Guo and Maria Krevvata and Michelle Peterson and Melissa Beelen and Jill Vanak and Arnob Banerjee and Hila Magen},
  year = {2023},
  journal = {HemaSphere},
  doi = {10.1097/01.hs9.0000967672.15362.d7},
  url = {https://doi.org/10.1097/01.hs9.0000967672.15362.d7}
}

RIS

TY  - JOUR
TI  - S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
AU  - Maria-Victoria Mateos
AU  - Daniel Morillo
AU  - Moshe Gatt
AU  - Michael Sebag
AU  - Kihyun Kim
AU  - Chang-Ki Min
AU  - Albert Oriol
AU  - Enrique Ocio
AU  - Sung-Soo Yoon
AU  - Yael Cohen
AU  - Michael Chu
AU  - Paula Rodríguez-Otero
AU  - Irit Avivi
AU  - Yue Guo
AU  - Maria Krevvata
AU  - Michelle Peterson
AU  - Melissa Beelen
AU  - Jill Vanak
AU  - Arnob Banerjee
AU  - Hila Magen
PY  - 2023
JO  - HemaSphere
DO  - 10.1097/01.hs9.0000967672.15362.d7
UR  - https://doi.org/10.1097/01.hs9.0000967672.15362.d7
ER  -

APA

Mateos, M., Morillo, D., Gatt, M., Sebag, M., Kim, K., Min, C., Oriol, A., Ocio, E., Yoon, S., Cohen, Y., Chu, M., Rodríguez-Otero, P., Avivi, I., Guo, Y., Krevvata, M., Peterson, M., Beelen, M., Vanak, J., Banerjee, A., & Magen, H. (2023). S190: FIRST RESULTS FROM THE REDIRECTT-1 STUDY WITH TECLISTAMAB (TEC) + TALQUETAMAB (TAL) SIMULTANEOUSLY TARGETING BCMA AND GPRC5D IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM). HemaSphere. https://doi.org/10.1097/01.hs9.0000967672.15362.d7

Source records

crossref · retrieved 2026-09-25T22:51:13.923Z